1. Home
  2. AYTU vs OP Comparison

AYTU vs OP Comparison

Compare AYTU & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • OP
  • Stock Information
  • Founded
  • AYTU N/A
  • OP 2021
  • Country
  • AYTU United States
  • OP Greece
  • Employees
  • AYTU N/A
  • OP N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • AYTU Health Care
  • OP
  • Exchange
  • AYTU Nasdaq
  • OP Nasdaq
  • Market Cap
  • AYTU 23.0M
  • OP 8.6M
  • IPO Year
  • AYTU N/A
  • OP N/A
  • Fundamental
  • Price
  • AYTU $2.29
  • OP $1.60
  • Analyst Decision
  • AYTU Strong Buy
  • OP
  • Analyst Count
  • AYTU 3
  • OP 0
  • Target Price
  • AYTU $9.17
  • OP N/A
  • AVG Volume (30 Days)
  • AYTU 401.9K
  • OP 438.7K
  • Earning Date
  • AYTU 11-12-2025
  • OP 08-08-2025
  • Dividend Yield
  • AYTU N/A
  • OP N/A
  • EPS Growth
  • AYTU N/A
  • OP N/A
  • EPS
  • AYTU N/A
  • OP N/A
  • Revenue
  • AYTU $66,382,000.00
  • OP $19,435,000.00
  • Revenue This Year
  • AYTU N/A
  • OP N/A
  • Revenue Next Year
  • AYTU $19.03
  • OP N/A
  • P/E Ratio
  • AYTU N/A
  • OP N/A
  • Revenue Growth
  • AYTU 1.84
  • OP N/A
  • 52 Week Low
  • AYTU $0.95
  • OP $1.07
  • 52 Week High
  • AYTU $2.82
  • OP $79.25
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 52.17
  • OP 57.81
  • Support Level
  • AYTU $2.25
  • OP $1.22
  • Resistance Level
  • AYTU $2.44
  • OP $2.08
  • Average True Range (ATR)
  • AYTU 0.16
  • OP 0.18
  • MACD
  • AYTU 0.03
  • OP 0.03
  • Stochastic Oscillator
  • AYTU 68.13
  • OP 36.89

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: